These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10266565)

  • 21. How a longstanding P & T Committee identifies and meets current therapeutic challenges.
    Stross J; de Leon R; Volger B
    Hosp Formul; 1991 Sep; 26(9):717-22, 724. PubMed ID: 10114003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P & T Committee interview: Establishing and maintaining a dynamic formulary.
    Rostand S; Lazarus H
    Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P & T Committee interview: communication and education contribute to an effective formulary system.
    Hinthorn D; Godwin H
    Hosp Formul; 1989 May; 24(5):281-4, 286-7. PubMed ID: 10292977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolution of an effective P & T Committee: advice from the chairman.
    Williams RR
    Hosp Formul; 1986 Dec; 21(12):1232-5, 1243. PubMed ID: 10279772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cephalosporin selection: view from a beleaguered P & T committee member.
    Talley JH
    Hosp Formul; 1986 Jan; 21(1):76-8, 83-4. PubMed ID: 10275082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P & T Committee problem-solving in a Canadian specialty hospital.
    Feld R
    Hosp Formul; 1986 Jul; 21(7):778-9, 783-4. PubMed ID: 10277344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulary issues at a pediatric hospital: experience at Children's National Medical Center.
    Cohen GJ; Allen SJ
    Hosp Formul; 1991 Jun; 26(6):500-10. PubMed ID: 10111371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to use structured decision making in developing therapeutic, cost-effective formulary systems.
    Crane VS
    Hosp Formul; 1993 Oct; 28(10):859-62, 865-7. PubMed ID: 10129135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The goals and functions of a P & T committee.
    Sudds TW; Williams RR
    Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achieving an effective committee through reorganization: the Ohio State University Hospital's experience.
    Lewis RP; Moore TD
    Hosp Formul; 1991 Feb; 26(2):120-30. PubMed ID: 10109143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs.
    Kile DM; McGrath ME; Schindel LP
    Hosp Formul; 1987 Feb; 22(2):176, 178, 181. PubMed ID: 10280289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Issues in formulary management: therapeutic interchange. Establishing guidelines: roundtable discussion, Part 1.
    Mahoney C; Cichon M; Cromer M; DeGiulio H; Renshaw B; Rodriguez FA; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():4-8. PubMed ID: 10122036
    [No Abstract]   [Full Text] [Related]  

  • 36. Achieving rational therapeutics through consensus-based protocols and follow-up.
    Quintiliani R; Gousse GC; Chow MS
    Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparing the P & T committee agenda for new drug requests.
    Standish RC; Evans PJ; Bell JE
    Hosp Formul; 1984 Sep; 19(9):792, 795-800. PubMed ID: 10267929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishing an enteral product formulary.
    Ford DB; Bergerson SL; Henderson P; Murphy J; Peter J
    J Am Diet Assoc; 1989 May; 89(5):681-3. PubMed ID: 2498416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The P & T committee: descriptive survey of activities and time requirements.
    Butler CO; Manchester R
    Hosp Formul; 1986 Jan; 21(1):89, 92-5. PubMed ID: 10275083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P & T Committee formulary requests: criteria for admission.
    Weintraub M; Guttmacher L
    Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.